Biogen

Medical Technology Firm

Based in DC

🤖

AI Overview

With $200K in lobbying spend across 4 quarterly filings, Biogen is an active lobbying client. Their lobbying covers 2 issue areas.

$200K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$200K

Issues Lobbied

Health Issues Medicare/Medicaid

Lobbying Firms

W Strategies, LLC

Lobbyists

Darren Willcox

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid

•FY 2017/2018 Labor/HHS appropriations bills as it relates to funding for newborn screening.
•Education about the RUSP (Recommended Uniform Screening Panel) as it relates to SMA.
•Education about inn

•Education about obstacles to patient access for coverage of rare disease therapies in Medicaid.

•FY 2019 Labor/HHS appropriations bills as it relates to funding for newborn screening.
•Education about the RUSP (Recommended Uniform Screening Panel) as it relates to SMA.
•Education about innovati

•Education about obstacles to patient access for coverage of rare disease therapies in Medicaid.
•H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D "donut hole" provision.

•FY 2019 Labor/HHS appropriations bill as it relates to funding for newborn screening.
•Education about the RUSP (Recommended Uniform Screening Panel) as it relates to SMA.
•Education about innovativ